Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days. (Q33504302)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days. |
scientific article |
Statements
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days (English)
Wolff I
Bench K
Beijnen JH
Bruntsch U
de Jong J
Groot Y
van Tellingen O
Wanders J
1 October 1996